Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
O6-Benzylguanine and BCNU in Colon and Rectal Carcinoma
NCT00005981Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jun 2000
- Primary completion
- Nov 2003
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 6-benzylguanine and carmustine in colorectal cancer (CRC), sponsored by Case Comprehensive Cancer Center. Primary endpoint: Response Rate. Started Jun 2000; status: completed.
02
Drugs
6-benzylguaninecarmustine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00005981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005981.